Incidence and risk factors for leukopenia in kidney transplant recipients receiving valganciclovir for cytomegalovirus prophylaxis

X Liang, O Famure, Y Li, SJ Kim - Progress in …, 2018 - journals.sagepub.com
Context: Valganciclovir is used not only for cytomegalovirus prophylaxis after kidney
transplantation but can also induce leukopenia, thereby making patients more susceptible to …
被引用次数：18 相关文章

Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis

X Liang, O Famure, Y Li, SJ Kim - Progress in Transplantation, 2018 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Context:</jats: title>< jats: p> Valganciclovir is used not only for
cytomegalovirus prophylaxis after kidney transplantation but can also induce leukopenia …

Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis.

X Liang, O Famure, Y Li, SJ Kim - Progress in Transplantation (Aliso …, 2018 - europepmc.org
Objective To determine the incidence and risk factors for leukopenia in patients receiving
valganciclovir for cytomegalovirus prophylaxis after kidney transplantation. Methods In this …

Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis

X Liang, O Famure, Y Li, SJ Kim - … in transplantation (Aliso …, 2018 - pubmed.ncbi.nlm.nih.gov
Context Valganciclovir is used not only for cytomegalovirus prophylaxis after kidney
transplantation but can also induce leukopenia, thereby making patients more susceptible to …